The following is a summary of “Association between triglyceride-glucose related indices and at-risk NASH in U.S. adults with NAFLD: results from NHANES 2017-2020,” published in the June 2025 issue of ...

Cite this: Non-alcoholic Fatty Liver Disease: Further Expression of the Metabolic Syndrome - Medscape - Mar 01, 2007. Abstract and Introduction Metabolic Syndrome ...

Nonalcoholic Fatty Liver Disease Medically reviewed by Jillian Foglesong Stabile MD, FAAFP, DABOM — Written by Jessica DiGiacinto and James Roland — Updated on June 26, 2025 MASLD vs MASH ...

Follow up. Patients with NAFLD should be followed up to monitor progression of both liver disease and metabolic syndrome. Abdominal ultrasonography cannot determine the severity of hepatic ...

Fatty liver disease, increasingly prevalent among young individuals, stems from unhealthy diets, sedentary lifestyles, and ...

Non-alcoholic fatty liver disease, a prevalent yet often silent condition, can be reversed through proactive lifestyle ...

The FDA based its decision on data from Phase 1, a randomized, double-blind, placebo-controlled study assessing the safety and efficacy of DD01 in overweight/obese subjects with type 2 diabetes ...

Non-alcoholic fatty liver disease (NAFLD) is common, affecting approximately 25% of the population in many developed countries. 1 The disease ranges from steatosis to non-alcoholic steatohepatitis ...

The research is important because almost 40% of the U.S. adult population is estimated to have metabolic syndrome, a cluster of conditions that significantly increase the risk of developing ...

Fatty liver is a common disease among people nowadays. Primarily affecting heavy drinkers, it is now among the most common liver disorders. What makes this disease more alarming is its silent ...

The findings could contribute to the development of targeted therapies for obesity, diabetes and other metabolic conditions in humans. The study was published in Cell Host & Microbe on June 18, 2025.